ICD-10-CM Billable Code

F13.98

Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code F13.98 refers to cases where a person has used sedatives, hypnotics, or anxiolytics and has developed other related disorders that aren’t specified elsewhere. These medications, often prescribed to treat anxiety and sleep issues, can sometimes lead to adverse effects or complications if misused or taken in larger amounts than recommended. This code helps healthcare professionals categorize and document such cases, emphasizing that these disorders are directly linked to the use of these medications.

Causes & Symptoms

Clinical Causes: Misuse or overuse of sedative, hypnotic, or anxiolytic medications Self-medication without medical supervision Combining these medications with alcohol or other substances Prolonged use leading to dependency or tolerance Incorrect dosage prescribed by healthcare providers Underlying mental health conditions requiring long-term treatment

Key Symptoms: Drowsiness or excessive sleepiness Confusion or forgetfulness Dizziness or lightheadedness Impaired coordination or balance Mood swings or irritability Difficulty concentrating Respiratory depression in severe cases Symptoms of dependency or withdrawal such as agitation or tremors

Diagnostic & Treatment

Diagnosis Path: Diagnosing disorders related to sedative, hypnotic, or anxiolytic use typically involves a comprehensive medical history review, focus on medication usage patterns, and assessment of symptoms. Healthcare providers may also conduct physical examinations, laboratory tests, and mental health evaluations to determine the extent of the disorder and rule out other conditions. In some cases, standardized assessment tools or questionnaires about substance use can aid in diagnosis.

Treatment Protocols: Treatment approaches for disorders linked to sedative, hypnotic, or anxiolytic use often include the following components: - **Medication management:** Tapering off or discontinuing the offending drugs under medical supervision. - **Psychotherapy:** Cognitive-behavioral therapy (CBT) and counseling to address underlying issues and develop healthier coping strategies. - **Monitoring and support:** Continuous medical supervision to manage withdrawal symptoms and prevent relapse. - **Lifestyle modifications:** Encouraging healthy sleep habits, stress management techniques, and avoiding substances that may exacerbate symptoms. - **Referral to specialists:** In some cases, involving addiction specialists or mental health professionals is necessary for comprehensive care. It’s essential to seek professional help when managing these disorders, as improper handling can lead to serious health complications or dependency.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F13.98 a billable ICD-10 code?
Yes, F13.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F13.98?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorders and any associated comorbidities for accurate reporting.

Cite this Clinical Reference